DK108586A - Benzimidazolderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler - Google Patents

Benzimidazolderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler Download PDF

Info

Publication number
DK108586A
DK108586A DK108586A DK108586A DK108586A DK 108586 A DK108586 A DK 108586A DK 108586 A DK108586 A DK 108586A DK 108586 A DK108586 A DK 108586A DK 108586 A DK108586 A DK 108586A
Authority
DK
Denmark
Prior art keywords
preparation
medicinal products
benzimidazole derivatives
additional salts
acid additional
Prior art date
Application number
DK108586A
Other languages
English (en)
Other versions
DK108586D0 (da
Inventor
Harsanyi K
A Maderspach
A Javor
G Hajos
G Fekete
L Szporny
P Tetenyi
K Csomor
E Karpati
B Hegedues
M Kapolnas
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of DK108586D0 publication Critical patent/DK108586D0/da
Publication of DK108586A publication Critical patent/DK108586A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
DK108586A 1985-03-11 1986-03-10 Benzimidazolderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler DK108586A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU85892A HU193951B (en) 1985-03-11 1985-03-11 Process for producing new sulfur-containing 5-substituted benzimidazol derivatives and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
DK108586D0 DK108586D0 (da) 1986-03-10
DK108586A true DK108586A (da) 1986-09-12

Family

ID=10951907

Family Applications (1)

Application Number Title Priority Date Filing Date
DK108586A DK108586A (da) 1985-03-11 1986-03-10 Benzimidazolderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler

Country Status (17)

Country Link
US (1) US4814329A (da)
JP (1) JPS61267559A (da)
CN (1) CN86102738A (da)
AT (1) ATA62986A (da)
AU (1) AU5461186A (da)
CH (1) CH672127A5 (da)
DD (1) DD246995A5 (da)
DE (1) DE3608032A1 (da)
DK (1) DK108586A (da)
ES (1) ES8705865A1 (da)
FI (1) FI861002A (da)
FR (1) FR2578541A1 (da)
GB (1) GB2173191B (da)
HU (1) HU193951B (da)
IL (1) IL78111A0 (da)
IT (1) IT1204473B (da)
SE (1) SE8601103L (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3508666A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische disulfide und ihre anwendung als immunmodulatoren
JPS62246587A (ja) * 1986-03-17 1987-10-27 ピ−ピ−ジ−　インダストリイズ，インコ−ポレイテツド 除草活性を有する置換ベンゾオキサゾロン（またはベンゾチアゾロン）化合物
US5098707A (en) * 1989-07-31 1992-03-24 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
US5030644A (en) * 1989-07-31 1991-07-09 Merck & Co., Inc. Imidazole compounds and their use as transglutaminase inhibitors
JP2524420B2 (ja) * 1990-05-16 1996-08-14 明治製菓株式会社 ピペリジン誘導体及びそれらを有効成分とする抗潰瘍剤
EP0474109A1 (de) * 1990-09-03 1992-03-11 Richter Gedeon Vegyeszeti Gyar R.T. Neue 5-Benzyl-substituierte Benzimidazolin-2-Thion-Derivate und Verfahren zu ihrer Herstellung
US5371102A (en) * 1992-03-11 1994-12-06 University Of Hawaii Compositions and methods of inhibiting thyroid activity
US5290801A (en) * 1992-05-29 1994-03-01 The Du Pont Merck Pharmaceutical Company Benzimidazoles for the treatment of atherosclerosis
US5387600A (en) * 1992-07-30 1995-02-07 Fuji Photo Film Co., Ltd. Treating arteriosclerosis using benzimidazole compositions
EP0788795B1 (en) * 1994-06-10 2002-11-13 Nauchno-Issledovatelsky Institut Farmakologii Akademii Meditsinskikh Nauk Pharmacologically active 2-mercaptobenzimidazole derivatives
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
ZA962879B (en) * 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
US6288100B1 (en) 1995-06-06 2001-09-11 American Home Products Corporation Benzimidazole derivatives
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5684030A (en) * 1995-06-07 1997-11-04 American Home Products Corporation 2-substituted benzimidazole derivatives
US5654436A (en) * 1995-06-07 1997-08-05 American Home Products Corporation 2-substituted benzimidazole derivatives
AU6369696A (en) 1995-07-17 1997-02-18 Fuji Photo Film Co., Ltd. Benzimidazole compounds
US5763473A (en) * 1996-12-06 1998-06-09 American Home Procucts Corporation Use of 2-substituted benzimidazole as smooth muscle cell proliferation inhibitors
US5900429A (en) * 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) * 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) * 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof
ES2289153T7 (es) * 2001-11-08 2009-06-18 Atrium Medical Corporation Dispositivo intraluminal con un revestimiento que contiene un agente terapeutico.
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036970A2 (en) * 2004-09-28 2006-04-06 Atrium Medical Corporation Method of thickening a coating using a drug
US9801982B2 (en) * 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US20090011116A1 (en) * 2004-09-28 2009-01-08 Atrium Medical Corporation Reducing template with coating receptacle containing a medical device to be coated
EP1811935B1 (en) 2004-09-28 2016-03-30 Atrium Medical Corporation Heat cured gel and method of making
US8367099B2 (en) 2004-09-28 2013-02-05 Atrium Medical Corporation Perforated fatty acid films
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US8312836B2 (en) 2004-09-28 2012-11-20 Atrium Medical Corporation Method and apparatus for application of a fresh coating on a medical device
US20060088596A1 (en) * 2004-09-28 2006-04-27 Atrium Medical Corporation Solubilizing a drug for use in a coating
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
AU2006304590A1 (en) * 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
EP2626091B1 (en) * 2006-11-06 2016-09-28 Atrium Medical Corporation Coated surgical mesh
US9492596B2 (en) * 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
WO2010051176A1 (en) * 2008-10-29 2010-05-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
EP2593141B1 (en) 2010-07-16 2018-07-04 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB634951A (en) * 1947-11-10 1950-03-29 John David Kendall Improvements in or relating to thiazolidone compounds
US2642430A (en) * 1949-04-27 1953-06-16 Monsanto Chemicals Hydroxy substituted aliphatic ether derivatives of nitrogen heterocyclics
DE1214083B (de) * 1964-08-14 1966-04-07 Agfa Gevaert Ag Lichtempfindliches photographisches Material mit mindestens einer lichtempfindlichen Silbersalzemulsionsschicht
FR6283M (da) * 1967-03-07 1968-09-02
JPS5529992B2 (da) * 1972-06-03 1980-08-07
HU169255B (da) * 1973-06-20 1976-10-28
JPS5736278B2 (da) * 1973-09-12 1982-08-03
BR7903775A (pt) * 1978-06-15 1980-02-05 Monsanto Co Processo para regular o crescimento de plantas leguminosas,e composicao para uso no mesmo
DE3216416A1 (de) * 1982-05-03 1983-11-03 Bayer Ag, 5090 Leverkusen Heteroarylthiovinyl-verbindungen, ein verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
US4492708A (en) * 1982-09-27 1985-01-08 Eli Lilly And Company Antiviral benzimidazoles
GB8313322D0 (en) * 1983-05-14 1983-06-22 Ciba Geigy Ag Heterocyclic-(cyclo)aliphatic carboxylic acids
GB8313321D0 (en) * 1983-05-14 1983-06-22 Ciba Geigy Ag Preparation of mercaptan substituted carboxylic acids
GB8412065D0 (en) * 1984-05-11 1984-06-20 Ciba Geigy Ag Preparation of carboxylic acid derivatives

Also Published As

Publication number Publication date
FR2578541A1 (fr) 1986-09-12
GB2173191A (en) 1986-10-08
FI861002A (fi) 1986-09-12
AU5461186A (en) 1986-10-16
DK108586D0 (da) 1986-03-10
DE3608032A1 (de) 1986-09-11
JPS61267559A (ja) 1986-11-27
CH672127A5 (da) 1989-10-31
SE8601103L (sv) 1986-09-12
ATA62986A (de) 1993-02-15
DD246995A5 (de) 1987-06-24
ES552896A0 (es) 1987-05-16
HU193951B (en) 1987-12-28
IT8619713A0 (it) 1986-03-11
IL78111A0 (en) 1986-07-31
HUT40085A (en) 1986-11-28
FI861002A0 (fi) 1986-03-11
SE8601103D0 (sv) 1986-03-10
US4814329A (en) 1989-03-21
GB8605971D0 (en) 1986-04-16
CN86102738A (zh) 1987-10-28
IT1204473B (it) 1989-03-01
ES8705865A1 (es) 1987-05-16
GB2173191B (en) 1989-02-01

Similar Documents

Publication Publication Date Title
DK108586D0 (da) Benzimidazolderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler
DK298984A (da) Tetrahydropyridazinoner eller syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter og disses fremstilling
DK266486D0 (da) Quinoloncarboxylsyreestere eller farmaceutisk anvendelige hydratereller syreadditionssalte deraf, deres fremstilling og anvendelse
DK521986D0 (da) Benzylaminderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse som fungicider
DK131887D0 (da) 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler
DK192788D0 (da) Substituerede anilidderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse
DK170986D0 (da) Substituerede 2,3,4,9-tetrahydro-1h-carbazol-1-eddikesyre-derivater, deres fremstilling og anvendelse som farmaceutika samt mellemprodukterved fremstillingen
DK118786A (da) Substituerede benzimidazolderivater, deres fremstilling og anvendelse som mavesyresekretionshaemmende farmaceutiske praeparater
DK103987A (da) Substituerede 1,3,4,9-tetrahydropyranooe3,4-baaindol-l-eddikesyrer, deres fremstilling og anvendelse som laegemidler
DK144885D0 (da) Substituerede 4-hydroxybenzopyraner eller farmaceutisk acceptable additionssalte deraf, deres fremstilling og anvendelse som laegemidler
DK614186D0 (da) Substituerede piperazin-1,4-naphtalendioner, deres fremstilling og anvendelse som laegemidler
DK154586A (da) Alkanoylanilider eller salte deraf, deres fremstilling og anvendelse som insekticider og arachmicider
DK555486A (da) Cephalosporiner eller salte deraf, deres fremstilling og anvendelse som laegemidler
DK501888A (da) 6-mercaptopurin-derivater, deres fremstilling og anvendelse som laegemidler
DK192588A (da) Pyrrolaldehyder eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK317184D0 (da) 2-azabicyclo(2,2,2)octanderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika
DK92582A (da) Alkylendiaminderivater n-oxider eller syreadditionssalte deraf deres fremstilling og anvendelse som antiarytmiske laegemidler
DK180086D0 (da) 12b-substituerede 1-hydroxymethyl-octahydroindolo(2,3-a)-quinolizinderivater eller isomere eller syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika
DK299983A (da) Racemiske eller optisk aktive apovincaminsyrederivater eller farmaceutisk aktive syreadditionssalte deraf, deres fremstilling og anvendelse
DK238089D0 (da) Substituerede 3-aminosydnoniminer eller farmaceutisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK183385D0 (da) Apovincaminolderivater eller syreadditionssalte deraf, deres fremstilling og anvendelser som farmaceutika
DK291986A (da) 10alfa-methoxy-6-methylergolinderivater eller fysiologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK292086A (da) 2-halogennicergolinderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse
DK482787D0 (da) Tetrahydroguinolinderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika
DK504386A (da) Gonadoliberinanaloge og farmaceutisk acceptable syreadditionssalte, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment